Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00377832 · ClinicalTrials.gov registry record · NA
Acetaminophen for Fetal Tachycardia: a Randomized Pilot Trial
A NA study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT00377832 is a NA study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 13 participants.
The verdict
NCT00377832, a NA study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The most common cause of fetal tachycardia is maternal fever. Fetal tachycardia often precedes the maternal fever, and fetal tachycardia confounds the interpretation of electronic fetal monitoring (EFM), increasing the rate of cesarean delivery for non-reassuring fetal status (NRFS). Our hypothesis is that treatment of fetal tachycardia with acetaminophen will significantly lower maternal body temperature and significantly lower baseline fetal heart rate (FHR). The importance is that interpretation of EFM will improve, thus allowing for a decrease in cesarean delivery for NRFS.
Interventions
- DRUG Acetaminophen 975 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2007-07 |
| Est. Completion | 2010-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00377832
The ClinicalTrials.gov registry entry for NCT00377832 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acetaminophen 975 mg is the first listed.
NCT00377832 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00377832 about?
NCT00377832 is a clinical study titled "Acetaminophen for Fetal Tachycardia: a Randomized Pilot Trial". The most common cause of fetal tachycardia is maternal fever. Fetal tachycardia often precedes the maternal fever, and fetal tachycardia confounds the interpretation of electronic fetal monitoring (EFM), increasing the rate of cesarean delivery for non-reassuring fetal status (NRFS). Our hypothesis ...
What is the current status of trial NCT00377832?
This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2007-07. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00377832?
The interventions under investigation include: Acetaminophen 975 mg (DRUG).
Who is sponsoring clinical trial NCT00377832?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.